5-HT5 receptors

Current Drug Targets: CNS and Neurological Disorders

Volumn 3, Issue 1, 2004, Pages 53-58

  Nelson, D L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT5A; 5 HT5B; 5 hydroxytyptamine; GPCR; Receptor; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CARBAMOYLTRYPTAMINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; 8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; ADENYLATE CYCLASE; BUFOTENINE; CLOZAPINE; CYCLIC AMP; CYPROHEPTADINE; DIHYDROERGOTAMINE; DOPAMINE; ERGOTAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; KETANSERIN; MELATONIN; METHYSERGIDE; METITEPINE; NORADRENALIN; PINDOLOL; PROPRANOLOL; RADIOLIGAND; SEROTONIN; SEROTONIN 5 RECEPTOR; SEROTONIN 5A RECEPTOR; SEROTONIN 5B RECEPTOR; SPIPERONE; SUMATRIPTAN; UNINDEXED DRUG; YOHIMBINE; ZACOPRIDE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

AMINO ACID SEQUENCE; BINDING AFFINITY; BRAIN NERVE CELL; CAROTID BODY; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHROMOSOMAL LOCALIZATION; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC LINKAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RAT; REVIEW; STOP CODON; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CLASSIFICATION; DRUG EFFECT; DRUG SCREENING; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MOLECULAR CLONING; NERVE CELL; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CLONING, MOLECULAR; DRUG EVALUATION; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEURONS; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 3042721517     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007043482606     Document Type: Review

References (17)

1. Plassat, J.L.; Boschert, U.; Amlaiky, N.; Hen, R. EMBO J., 1992, 11, 4779-86.
2. Matthes, H.; Boschert, U.; Amlaiky, N.; Grailhe, R.; Plassat, J.L.; Muscatelli, F.; Mattei, M.G.; Hen, R. Mol. Pharmacol., 1993, 43, 313-9.
3. Erlander, M.G.; Lovenberg, T.W.; Baron, B.M.; de Lecea, L.; Danielson, P.E.; Racke, M.; Slone, A.L.; Siegel, B.W.; Foye, P.E.; Cannon, K.; Burns, J.E.; Sutcliffe, J. Proc. Natl. Acad. Sci. U S A. 1993, 90, 3452-6.
4. Wisden, W.; Parker, E.M.; Mahle, C.D.; Grisel, D.A.; Nowak, H.P.; Yocca, F.D.; Felder, C.C.; Seeburg, P.H.; Voigt, M.M. FEBS Lett., 1993, 333, 25-31.
5. Rees, S.; den Daas, I.; Foord S.; Goodson S.; Bull, D.; Kilpatrick, G.; Lee, M. FEBS Lett., 1994, 355, 242-6.
6. Grailhe, R.; Grabtree, G.W.; Hen, R. Eur. J. Pharmacol. 2001, 418, 157-67
7. Carson, M.J.; Thomas, E.A.; Danielson, P.E.; Sutcliffe, J.G. Glia. 1996, 17, 317-26.
8. Grailhe, R.; Waeber, C.; Dulawa, S.C.; Hornung, J.P.; Zhuang, X.; Brunner, D.; Geyer, M.A.; Hen, R. Neuron. 1999, 22, 581-91.
9. Hirst, W.D.; Cheung, N.Y.; Rattray, M.; Price, G.W.; Wilkin, G.P. Brain Res Mol Brain Res. 1998, 61, 90-9.
10. Duncan, M.J.; Jennes, L.; Jefferson, J.B.; Brownfield, M.S. Brain Res. 2000, 869, 178-85.
11. Geurts, F.J.; De Schutter, E.; Timmermans, J.P. J. Chem. Neuroanat. 2002, 24, 65-74.
12. Wang, Z.Y.; Keith, I.M.; Beckman, M.J.; Brownfield, M.S.; Vidruk, E.H.; Bisgard, G.E. Neurosci. Lett., 2000, 278, 9-12.
13. Hurley, P.T.; McMahon, R.A.; Fanning, P.; O'Boyle, K.M.; Rogers, M.; Martin, F. Br. J. Pharmacol. 1998, 124, 1238-44.
14. Francken, B.J.; Jurzak, M.; Vanhauwe, J.F.; Luyten, W.H.; Leysen, J.E. Eu.r J. Pharmacol. 1998, 361, 299-309.
15. Francken, B.J.; Josson, K.; Lijnen, P.; Jurzak, M.; Luyten, W.H.; Leysen, J.E. Mo.l Pharmacol. 2000, 57, 1034-44.
16. Noda, M.; Yasuda, S.; Okada, M.; Higashida, H.; Shimada, A.; Iwata, N.; Ozaki, N.; Nishikawa, K.; Shirasawa, S.; Uchida, M.; Aoki, S.; Wada, K. J. Neurochem., 2003, 84, 222-32.
17. Khorana, N.; Purohit, A.; Herrick-Davis, K.; Teitler, M.; Glennon, R.A. Bioorg. Med. Chem., 2003, 11, 717-22.